Trazodone: Tổng quan về tính chất dược lý và ứng dụng điều trị trong trầm cảm và lo âu

Agnoli, A.: Control of levodopa-induced and chronic tardive dyskinesias by trazodone; in Gershon, Rickels and Silvestrini (Eds) Proceedings of 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, July 9–14, 1978. Trazodone, p.64 (Excerpta Medica, Amsterdam 1980). Agnoli, A.; Piccione, M.; Casacchia, M. and Fazio, C.: Trazodone versus desipramine: A double-blind study on the rapidity of the antidepressive effect; in Ban and Silvestrini (Eds) Trazodone, Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9, Modern Problems of Pharmacopsychiatry, p. 190 (Karger, Basel 1974). Agnoli, A.; Piccione, M.; Dionisio, A.; De Gregorio, M. and Casacchia, M.. Psychopharmacological effects of Trazodone, results of clinical studies. Journal de Pharmacologie Clinique 2(4): 219–225 (1975). Agnoli, A.; Ruggieri, S.; Cerone, G. and Sconci, V.: Trazodone in acute and chronic iatrogenic dyskinesias; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, pp. 109–116 (Edizioni Luigi Pozzi, Rome 1978). Allori, L.; Cioli, V. and Silvestrini, B.: Experimental and clinical data indicating a potential use of Trazodone in acute stroke. Current Therapeutic Research 18(3): 410–416 (1975). Allori, L.; Catanese, B.; Cioli, V. and Interdonato, N.: A study of serum levels of trazodone produced in man following single or repeated oral administrations. Bollettino Chimico Farmaceutico 117: 530 (1978). Amin, M.; Ban, T.A. and Klingner, A.: Trazodone in the treatment of affective disorders. Current Therapeutic Research 15(10s): 781–788 (1973). Amin, M.; Hontela, D.; Kussin, D. et al.: A placebo-controlled clinical trial. Psychopharmacology Bulletin 12: 45–46 (1976). Angellucci, L. and Bolle, P.: Considerations on biochemical studies with Trazodone; in Ban and Silvestrini (Eds) Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9, Modern Problems of Pharmacopsychiatry, pp.65–75 (Karger, Basel 1974). Antonelli, F.; De Gregorio, M. and Dionisio, A.: Trazodone in the treatment of psychoneuroses: A double-blind study. Current Therapeutic Research 15(10s): 799–803 (1973). Antonelli, F.; De Gregorio, M.; Dionisio, A. and Peruzy, D.: Trazodone in the treatment of neurosis; in Ban and Silvestrini (Eds) Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9, Modern Problems of Pharmacopsychiatry, pp. 127–139 (Karger, Basel 1974). Argenta, G.: Trazodone in the treatment of anxiety. Policbnuo Sezione Medica 79: 174–180 (1972). Baiocchi, L.; Frigerio, A.; Giannangeli, M. and Palazzo, G.: Basic metabolites of trazodone in humans. Arzneimittel-Forschung 24(10): 1699–1706 (1974). Ban, T.A. and Lehmann, H.E.: Systematic clinical studies with trazodone methodological aspects. Current Therapeutic Research 15(10s): 764–768 (1973). Ban, T.A.; Lehmann, H.E.; Amin, M.; Bronheim, L.A.; Klingner, A.; Nair, N.P.V.; Galvan, L; Vergara, L. and Zoch, C: Differential effects of trazodone in depressed, schizophrenic and geriatric patients. International Journal of Clinical Pharmacology, Therapy and Toxicology 9(1): 23–27 (1974). Baran, L; Maj, J.; Rogoz, and Skuza, G.: On the central anti-serotonin action of trazodone. Polish Journal of Pharmacology 31: 25–33 (1979). Barreca, T.; Magnani, G., Milesi, G.M. and Rolandi, E.: Effect of trazodone administration on serum prolactin levels in healthy subjects. Clinical Psychology and Psychiatry 6: 449 (1978). Bartilotti, R. and Dionisio, A.: Un nuovo ‘tranquillante minore’ nella cura delle psiconevrosi. Gazzetta Medica Italiana 132: 425 (1973). Bergamasco, B.; Benna, P.; Furlan, P.M.; Riccio, A.; Fantini, M. and Monaco, F.: The use of trazodone in the depressive syndromes; in Morozov, Saarma and Silvestrini (Eds) Trazodone, pp.70–74 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Bergamini, L.; Bergamasco, B.; Furlan, P.M. et al.: Clinical evaluation of trazodone treatment in the depression syndrome; in Morozov et al. (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, pp.91–94 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Bueno, J.R., Versiani Caldeira, M.V.; Rocha, A.V. and Mundim, F.D.: Anti-anxiety effects of trazodone (A double blind study with diazepam and placebo). Revista Brasileira de Medicina 33(2): 73–77 (1976). Bickel, M.H.: Poisoning by tricyclic antidepressant drugs. General and pharmacokinetic considerations. International Journal of Clinical Pharmacology 11: 145 (1975). Boissier, J.R.; Portmann-Cristesco, E.; Soubrié, P. and Fichelle, J.: Pharmacological and biochemical features of trazodone; in Ban and Silvestrini (Eds) Trazodone. Modern Problems of Pharmacopsychiatry Vol. 9, pp. 18–28 (Karger, Basel 1974). Bompani, R. and Castello, S.: Il trazodone in terapia geriatrica. Rassegna Geriatrica 11: 167 (1975). Bufalari, A.: The use of Trazodone in internal medicine. Clinica Europea 11: 1–11 (1972). Cassano, G.B.: Trazodone in schizophrenia; in Gershon, Rickels and Silvestrini (Eds) trazodone: A New Broad-spectrum Antidepressant, Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9th–14th, 1978, pp.75–82 (Excerpta Medica, Amsterdam 1980). Cassano, G.B.; Castrogiovanni, P. and Conti, L.: Clinical evaluation of Trazodone in the treatment of depression; in Ban and Silvestrini (Eds) Trazodone, Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9, Modern Problems of Pharmacopsychiatry, pp. 199–204 (Karger, Basel 1974). Cassano, G.B.; Chiozzi, M. and Fornaro, P.: Clinical experiences with trazodone; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, Proceedings of USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp.50–57 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Catanese, B. and Lisciani, R.: Investigations on the absorption and distribution of Trazodone or AF 1161 in rats, dogs and humans. Bolletino Chimico Farmaceutico 109: 369–373 (1970). Ceino, A.: Considerazioni sull’uso del trittico (trazodone) nelle turbe psichiche dell’eta senile. Rassegna Geriatrica 8: 71 (1972). Cianchetti, C. and Gainotti, G.: Controlled clinical trial on the anti-depressant and antianxiety activity of a new psycho-drug: AF-1161. Gazetta Internazionale di Medicina e Chirurgia 73(24): 1–13 (1968). Cioffi, F.; Mattioli, G.; Pozzi, O. and Rinaldi, F.: Additional data on the anti-depressant action of a new psychodrug, AF-1161. Rassegna Internazionale di Clinica e Terapia 49(23): 1–9 (1969). Clements-Jewery, S.: The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserin. Neuropharmacology 17: 779–781 (1978). Clements-Jewery, S.; Robson, P.A. and Chidley, L.J.: Biochemical investigations into the mode of action of trazodone. Neuropharmacology 19: 1165 (1980). Cozzolino, G.; Pazzaglia, I.; De Gaetano, V. and Macri, M.: Clinical investigation on the possible interaction between anti-coagulants and a new psychotropic drug (Trazodone). Clinica Europa 11: 593–607 (1972). Daniele, S. and Fiore, C.: Hypotensive effect on intraocular tension by AF-1161 (Trazodone). Annales di Ottalmologia e Clinica Oculistica (pharma) 98: 1–6 (1972). De Feo, G.; Piccinelli, D. and Silvestrini, B.: Effetti di alcuni farmaci sulla motilità intestinale del topo normale e del topo trattato con tremorina. Farmaco Edizione Pratica 26: 123 (1971). De Gregorio, M. and Dionisio, A.: A controlled clinical study of a new antidepressant. Panminerva Medica 13(1-2): 27–30 (1971). De Gregorio, M.; Dionisio, A.; Fornaro, P. and Ghiozzi, M: Review of clinical studies with trazodone; in Morozov; Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, pp.38–49 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Derkervorkian, K.; Ban, T.A. and Hontela, S.: Trazodone in the treatment of geriatric patients: A standard controlled clinical trial. Psychopharmacology Bulletin 12(2): 46 (1976). Deutsch, M.; Ban, T.A. and Lehmann, H.E.: A standard-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacology Bulletin 13(3): 13–14 (1977). Di Giuseppe, B. and Cesarini, F.: A new psychotropic drug in the treatment of depression. Clin. Neuropsich. 5: 1–11 (1969). Di Giuseppe, B. and Dionisio, A.: Un nuovo psicofarmaco il trazodone nella terapia delle psicosi cicloidi. La Clinica Neuropsichiatrica 6: 5 (1970). Domino, E.F.: Discussion on pharmacological features of trazodone; in Ban and Silvestrini (Eds) Trazodone, Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.52–55 (Karger, Basel 1974). Eckmann, F. and Voelkel, A.: Double blind clinical studies with trazodone; in Antonelli (Ed) Therapy in Psychosomatic Medicine, pp.84–87 (Edizioni Luigi Pozzi, Rome 1976). Eckmann, F.; Boefers, U.; Guthy, H.; Harrach, A.; Krippendorf, B. and Siedow, H.: Clinical trials with Thombran, results of double-blind studies; in Gershon, Rickels and Silvestrini (Eds) Trazodone — a new Broad Spectrum Antidepressant pp.69–74 (Excerpta Medica, Amsterdam 1980). Escobar, J.I.; Gomez, J.; Constain, C; Rey, J. and Santacruz, H.: Controlled clinical trial with trazodone, a novel antidepressant. A South American experience. Journal of Clinical Pharmacology 20(2,3): 124–130 (1980). Fabre, L.F.; McLendon, D.M. and Gainey, A.: Trazodone efficacy in depression: A double-blind comparison with imipramine and placebo in day-hospital type patients. Current Therapeutic Research 25(6): 827–834 (1979). Fadda, F.; Stefanini, E.; Medda, L. and Gessa, G.L.: Selective inhibition with trazodone of the uptake of 5-hydroxytryptamine by synaptosomal preparations of rat brain. Revista Farmacologia e Terapia 7(1): 69–76 (1976). Faleni, R.A.: Clinical evaluation of the antidepressant activity of trazodone. Its importance in gerontopsychiatry; in Antonelli (Ed) Therapy in Psychosomatic Medicine, pp. 100–112 (Edizioni Luigi Pozzi, Rome 1976). Feighner, J.P.: Trazodone, a triazolopyridine derivative, in primary depressive disorder. Journal of Clinical Psychiatry 41(7): 250–255 (1980). Fujita, T.; Yamato, C; Takahashi, T. and Ohtake, S.: Absorption, tissue distribution, excretion in metabolism of 14C-labelled trazodone hydrochloride in rats and rabbits; in Ban and Silvestrini (Eds) Trazodone, Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.54–56 (Karger, Basel 1974). Furlan, P.M.; Berganasco, B.; Bergamini, L.; Riccio, A.; Benna, P. and Fantini, M.: Study of the long-term use of trazodone in involutional, neurotic and masked depressions, in Gershon, Rickels and Silvestrini (Eds) Trazodone: A new broad-spectrum antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum 1978 pp.54–57 (Excerpta Medica, Amsterdam 1980). Galperina, LE. and Orbachevskaya, V.D.: Peculiarities in the clinical use of trazodone for depressive states of various origin; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, pp.81–85 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Galvan, L; Nair, N.P.V.; Russin, D. and Ban, T.A.: Trazodone in the treatment of schizophrenias. Current Therapeutic Research 15(10s): 776–780 (1973). Garattini, S.: Biochemical studies with trazodone, a new psychoactive drug; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.29–46 (Karger, Basel 1974). Garattini, S.; De Gaetano, G.; Samanin, R.; Bernasconi, S. and Roncaglioni, M.C.: Effects of trazodone on serotonin in the brain and platelets of the rat. Biochemical Pharmacology 25: 13–16 (1976). Gatti, G.L.: Effects of trimeprazine, trimeprimine and trazodone on conditioned behaviour of rats using a method of discriminated continuous avoidance; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9, Modern Problems of Pharmacopsychiatry, pp.47–51 (Karger, Basel 1974). Gentili, E. and Dionisio, A.: Clinical data on the study of a new psychotropic drug — trazodone (AF-1161). Revista di Neuropsichiatria e Scienze Affini 15: 185–194 (1969). Gerner, R.; Estabrook, W.; Steuer, J. and Jarvik, L.: Treatment of geriatric depression with trazodone, imipramine, and placebo: A double-blind study. Journal of Clinical Psychiatry 41(6): 216–220 (1980). Gershon, S. and Newton, R.: A multicentered controlled evaluation of trazodone in endogenous depression; in Gershon, Rickels and Silvestrini (Eds) Trazodone: A new broad-spectrum antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.42–53 (Excerpta Medica, Amsterdam 1980). Goldberg, H.L. and Finnerty, R.J.: Trazodone in the treatment of neurotic depression. J. Clin. Psych. 41: 430 (1980). Gomoll, A.W. and Byrne, J.E.: Trazodone and imipramine: Comparative effects of canine cardiac conduction. European Journal of Pharmacology 57: 335–342 (1979). Gomoll, A.W.; Byrne, J.E. and Deitchman, D.: Hemodynamic and cardiac actions of trazodone and imipramine in the anesthetized dog. Life Science 24: 1841–1848 (1979). Gunella, G.: Trazodone’s effects on patients with partial or total ventilatory insufficiency; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp. 167–172 (Karger, Basel 1974). Gunella, G. and Melica, A.: Trazodone’s effects on patients with partial or total ventilatory insufficiency. Giornale di Clinica Medica 54: 175–182 (1973). Hwang, E.C. and van Woert, M.H.: Serotonin-norepinephrine interactions in the tremorolytic actions of phenoxybenzamine and trazodone. Pharmacology Biochemistry and Behaviour 10:27–29 (1979). Ivanets, N.N.; Igonin, A.L. and Savchenko, L.M.: Trazodone in chronic alcoholism; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp. 105–107 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Jauch, V.R.; Kopitar, Z.; Prox, A. and Zimmer, A.: Pharmakokinetik und Stoffwechsel von Trazodone beim Menschen. Arzneimittel-Forschung 26(11): 2084–2089 (1976). Jefferson, J.W.: A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosomatic Medicine 37: 160 (1975). Karniol, I.G.; Dalton, J. and Lader, M.: Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects. Current Therapeutic Research 20(3): 337–348 (1976). Kellams, J.J.; Klapper, M.H. and Small, J.G.: Trazodone. A new antidepressant: Efficacy and safety in endogenous depression. Journal of Clinical Psychiatry 40: 390–395 (1979). Knobel, M.: Trazodone and psychosomatic medicine. Current Therapeutic Research 15(10s): 789–798 (1973). Knobel, M.: The use of trazodone in psychosomatic medicine. Psychotherapy and Psychosomatics 24: 141–145 (1974). Koss, F.W. and Busch, U.: Pharmacokinetics and metabolism of trazodone in different species; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp.11–20 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Koss, F.W. and Busch, U.: Trazodone as an example — drug levels in the blood and brain; in Gershon, Rickels and Silvestrini (Eds) Trazodone — A New Broad-spectrum Antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.27–33 (Excerpta Medica, Amsterdam 1980). Lapierre, Y.D.; Sussman, P. and Ghadirian, A.: Differential antidepressant properties of trazodone and amitriptyline in agitated and retarded depression. Current Therapeutic Research 28: 845(1980). Larochelle, P.; Hamet, P. and Enjalbert, M.: Responses to tyramine and norepinephrine after imipramine and trazodone. Clinical Pharmacology and Therapeutics 26: 24–30 (1979). Lehmann, H.E. and Ban, T.A.: A placebo-controlled clinical study with trazodone in schizophrenic patients. Psychopharmacology Bulletin 13(3): 11–12 (1977). Lehmann, H.E.; Ban, T.A. and Clark, R.: Trazodone in secondary depressions. Presented at a round table discussion on trazodone at the 1st World Congress of Biological Psychiatry, Buenos Aires, September 24–28, 1974. Lehmann, H.E.; Ban, T.A.; Hontela, S.; Nair, N.V.P. and Stewart, J.A.: An uncontrolled clinical trial carried out in Verdun, Quebec, Canada. Psychopharmacology Bulletin 12: 42–43 (1976). Lehmann, H.E.; Ban, T.A. and Schwartz, G.V.: Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161). International Pharmacopsychiatry 10(1): 42–53 (1975). Lisciani, R.; Baldini, A.; Benedetti, D.; Campana, A. and Barcellona, P.S.: Acute cardiovascular toxicity of trazodone, etoperidone and imipramine in rats. Toxicology 10: 151–158 (1978). Lisciani, R.; Baldini, A.; de Feo, G. and Silvestrini, B.: Pharmacological investigations on etoperidone, a new psychotropic agent. Arzneimittel-Forschung 28: 417 (1978). Loeb, C. and Roccatagliata, G.: Clinical evaluation of the effect of trazodone on involuntary movements; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp. 124–130 (Edizioni Luigi Pozziz S.p.A., Rome 1978). Loeb, C. and Roccatagliata, G.: Trazodone therapy in depressed patients; in Gershon, Rickels and Silvestrini (Eds) Trazodone — A New Broad-spectrum Antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.60–63 (Excerpta Medica, Amsterdam 1980). Longo, V.G. and De Carolis, A.S.: Pharmacological features of trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp.4–10 (Karger, Basel 1974). Lopez Zanon, A.: Clinical experience with trazodone in the treatment of psychiatric patients; in Ban and Silvestrini, Modern Problems in Pharmacopsychiatry Vol. 9, pp.190–198 (Karger, Basel 1974). Lucchi, R.: Trittico e stati depressivi dell’età involutiva Rassegna Geriatrica 11: 23 (1975). Maj, J.; Palider, W. and Rawlow, A.: Trazodone, a central serotonin antagonist and agonist. Journal of Neural Transmission 44(3): 237–248 (1979). Maj, J.; Baran, L.; Bigajska, K. and Rawlów, A.: Effects of trazodone on the central serotonergic system; in Gershon, Rickels and Silvestrini (Eds) Trazodone — a New Broad-spectrum Antidepressant pp.34–38 (Excerpta Medica, Amsterdam 1980). Massotti, M.; De Carolis, A.S. and Longo, V.G.: Effects of trazodone on behaviour and brain amine content of mice. Current Therapeutic Research 19(1): 133–139 (1976). Mazzi, C; Montanini, R. and Riva, L.P.: Studio dell’azione del trazodone sulla secrezione di ormoni ipofisari. Minerva Medica 70(13): 935–940 (1979). Miura, S.: Preliminary clinical studies with trazodone in the treatment of neurotic patients; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, QueBEC, October 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp.140–145 (Karger, Basel 1974). Montanini, R.: EEG findings in geriatric patients treated with trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp.160–166 (Karger, Basel 1974). Mrozikiewicz, A.; Strzyzewski, W.; Kapelski, Z. and Sydor, L: The influence of trazodone on the circulatory system in patients with endogenous depression. 1. Basic circulation parameters. Archivum Immunolgiae et Therapiae Experimentalis 24(4): 459–463 (1976). Munday, B.; Kendall, M.J.; Mitchard, M. and Betts, T.A.: A single dose study of trazodone with an assessment of its effect on mood and arousal. British Journal of Clinical Pharmacology 2: 19 (1975). Muratorio, A.; Maggini, C; Coccagna, G. and Guazzelli, M.: Polygraphic study of the all-night sleep pattern in neurotic and depressed patients treated with Trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Que, October 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp. 182–189 (Karger, Basel 1974). Murphy, J.E. and Ankier, S.I.: An evaluation of trazodone in the treatment of depression. Neuropharmacology 19: 1217 (1980). Nair, N.P.V.; Ban, T.A.; Hontela, S. and Clarke, R.: Trazodone in the treatment of organic brain syndrome, with special reference to psychogeriatrics. Current Therapeutic Research 15(10s): 769–775 (1973). Nair, N.P.V.; Hontela, S. and Schwartz, G.: Lack of effect of trazodone on serum prolactin levels in depression. IRCS Medical Science: Clinical Pharmacology and Therapeutics 7: 166 (1979). Paciaroni, E.: Clinical report on the use of low doses of trazodone in geriatric patients. Policlinico 80: 61–66 (1973). Paciaroni, E.: Il trittico nel paziente geriatrico. Rassegna Geriatrica 11: 117 (1975). Paciaroni, E.: Trazodone em pacientes geriatricos urn estudo comparativo contra lorazepam e placebo. Revista Brasileva de Medicina 34(5): 327–330 (1977). Pariante, F.: Clinical evaluation of Af-1161 in psychiatry. A cross-over double blind trial. Rivista di neuropsichiatria e Scienze Affini 17: l–19z (1971). Pariante, F.: Clinical effect of intravenous trazodone administration in severe depression; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.176–181 (Karger, Basel 1974). Patten, B.M.; Mendell, J.; Bruun, B.; Curtin, W. and Carter, S.: Double-blind study of the effects of dexamethasone on acute stroke. Neurology (Minneap.) 22: 377–383 (1972). Pecknold, J.C.; Putzolu, S.; Ban, T.A. et al.: Trazodone: Clinical and biochemical studies. I. An uncontrolled clinical trial in depression. Psychopharmacology Bulletin 12: 43–44 (1976). Peet, M. and Behagel, H.: Mianserin: A decade of scientific development. Proceedings of a Symposium on Mianserin, October 1977. British Journal of Clinical Pharmacology 5(Suppl.): 5s (1978). Pennesi, S.O.: A new psychotropic drug, trittico, for the treatment of neurosis. Rivista di Neuropsichiatria e Scienze Affini 17: 51–58 (1971). Perfetti, S.; Noya, E.; Bellucci, R.; Capperucci, U. and Massa, F.: Studi sugli effetti del trazodone sulla pressione intraoculare. Bollettino Di Oculistica 58: 649 (1979). Peterova, E. and Vencovsky, E.: Comparison of the clinical antidepressant effects of trazodone and imipramine; in Gershon, Rickels and Silvestrini (Eds) Trazodone — a New Broad-spectrum Antidepressant pp.58–60 (Excerpta Medica, Amsterdam 1980). Pierce, D.: A comparison of trazodone and dothiepin in depression. Neuropharmacology 19: 1219(1980). Poeldinger, W.: Experience with trazodone (Trittico®) in outpatient therapy; in Gershon, Rickels and Silvestrini (Eds) Trazodone — A New Broad-spectrum Antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.39–41 (Excerpta Medica, Amsterdam 1980). Pohlmeier, H.; De Gregorio, M. and Sieroslawski, H.: Clinical data on trazodone: A review of the literature; in Gershon, Rickels and Silvestrini (Eds) Trazodone — A New Broadspectrum Antidepressant. Proceedings of the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.8–26 (Excerpta Medica, Amsterdam 1980). Pozzi, O.; Margherita, G. and Rinaldi, F.. A double-blind, crossover clinical investigation of AF/1161 antidepressant activity. Quad. Osped. Psichiat. Interprovinciale Salentino 2: 257–258 (1967). Putzolu, S.; Pecknold, J.G.; Baiocchi, L. et al.: Trazodone clinical and biochemical studies. II. Blood levels and therapeutic responsiveness. Psychopharmacology Bulletin 12: 40–41 (1976). Quock, R.M.: Effect of trazodone and fluxetine pretreatment upon fenfluramine — and apomorphine-induced hyperthermia in the rabbit. Pharmacological Research Communications 9(8): 737–741 (1977). Riblet, L.A.; Gatewood, CF. and Mayol, R.F.: Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolated rat brain synaptosomes. Psychopharmacology 63: 99–101 (1979). Rickels, K.; Csanalosi, H.; Newman, A.; Hurowitz, J.; Werblowsky, J. and White, N.: Trazodone and amitriptyline in depressed outpatients — a controlled study; in Gershon, Rickels and Silvestrini (Eds), Trazodone — A New Broadspectrum Antidepressant. Proceedings of the 1 lth Congress of the Collegium Internationale Neuro-Psychopharmacologicum July 9–14, 1978, pp.86–101 (Excerpta Medica, Amsterdam 1980). Rivett, K.F. and Barcellona, P.S.: Toxicology of trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.76–86 (Karger, Basel 1974). Rivett, K.F.; Hunter, B.; Batham, P.; Street, A.E.; Heywood, R. and Cherry, C.P.: Trazodone oral toxicity to rats — repeated administration for 78 weeks with interim sacrifice at 26 weeks — final report. Huntingdon Research Centre, England. Unpublished 1973. Roccatagliata, G.; Abbruzzese, G.; Albano, C. and Gandolfo, C: Trazodone intravenoously administered in depressive syndromes. Drugs in Experimental and Clinical Research 1(1,2): 389–395 (1977). Roccatagliata, G.; De Cecco, L; Rossato, P. and Albano, C: Trazodone intravenously administered and plasma prolactin levels. International Pharmacopsychiatry 14: 260–263 (1979). Roccatagliata, G.; Albano, C; Maffini, M. and Farelli, S.: Alcohol withdrawal syndrome: Treatment with trazodone. International Pharmacopsychiatry 15: 105 (1980). Rudenko, G.M., Muzychenko, A.P. and Shatrova, M.G.: Comparative clinical studies with trazodone in the treatment of depressive and neurotic states; in Morozov, Saarma and Silvestrini (Eds), Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp.58–69 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Saarma, J.M. and Aadamsoo, A.M.: Intravenous infusions of trazodone in the treatment of depressed patients-, in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy, pp.95–99 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Schwarz, D. and Blendl, M.: Sedative and anxiety-reducing properties of trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973, Vol. 9. Modern Problems of Pharmacopsychiatry, pp.146–156 (Karger, Basel 1974). Severny, A.A.: Trazodone’s psychotropic effect in depressions as part of manic-depressive psychosis and schizophrenia; in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977, pp.75–79 (Edizioni Luigi Pozzi S.p.A., Rome 1978). Shibahara, Y.: Clinical experiences with trazodone on various psychoneuroses in Japan; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973. Vol. 9 Modern Problems of Pharmacopsychiatry, pp.173–175 (Karger, Basel 1974). Singh, A.N.; Saxena, B. and Helson, H.L.: A controlled clinical study of trazodone in chronic schizophrenic patients with pronounced depressive symptomatology. Current Therapeutic Research 23(4): 485–501 (1978). Silvestrini, B.: Introductory remarks on trazodone and its position in treatment of psychiatric diseases; in Gershon, Rickels and Silvestrini (Eds) Trazodone a new broad spectrum antidepressant. Proceedings of a Symposium held during the 11th Congress of the Collegium Internationale Neuro-Psychopharmacologium. Vienna, 1978, pp.34–38 (Excerpta Medica, Amsterdam 1980). Silvestrini, B. and Lisciani, R.: Pharmacology of trazodone. Round Table Discussion choneuroses Trazodone, A New Psychotropic Agent, Amsterdam, 1973. Current Therapeutic Research 15: 749(1973). Silvestrini, B. and Lisciani, R.: Experimental data suggesting an adrenergic mechanism in the production of Parkinsonian symptoms. Current Therapeutic Research 20(5): 716–724 (1976). Silvestrini, B. and Quadri, E.. Investigations on the specificity of the so-called analgesic activity of non-narcotic drugs. European Journal of Pharmacology 12: 231 (1970). Silvestrini, B.; Cioli, V.; Burberi, S. and Catanese, B.: Pharmacological properties of AF 1161, a new psychotropic drug. International Journal of Neuropharmacology 7: 587 (1968). Silvestrini, B.; Lisciani, R. and De Gregorio, M.. Trazodone. Pharmacological and Biochemical Properties of Drug Substances, Vol. III. In press (1980). Stefanini, E.; Fadda, F.; Medda, L. and Gessa, G.L.: Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent. Life Sciences 18: 1459–1466 (1976a). Stefanini, E.; Fadda, F.; Porceddu, M.L. and Gessa, G.L.: Effect of trazodone on brain dopamine metabolism. Journal of Pharmacy and Pharmacology 28: 925–927 (1976b). Stewart, J.A.; Ban, T.A. and Lehmann, H.E.: A summary of systematic studies. Psychopharmacology Bulletin 12: 47 (1976). Suzuki, Y.: Teratogenicity and placental transfer of trazodone; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp.87–94 (Karger, Basel 1974). Taylor, DP., Hyslop, D.K. and Riblet, A.: Trazodone, a new nontricyclic antidepressant without anticholinergic activity. Biochemical Pharmacology 29: 2149–2150 (1980). Trapp, G.A.; Handorf, C.R. and Larach, V.: Trazodone in the treatment of depressed inpatients. Psychopharmacology Bulletin 15(3): 25–27 (1979). Turrisi, E.; Esposito, G.; Russo, A. and Vitagliano, A.: Clinical trial with trazodone in the geriatric field. Acta Gerontologica 25: 279–292 (1975). Van Zwieten, P.A.: Inhibition of the central hypotensive effect of clonidine byztrazodone, a novel antidepressant. Pharmacology 15: 331–336 (1977). Vergara, L.E.; Ban, T.A.; Lehmann, H.E. and Stewart, J.A.: An uncontrolled clinical trial carried out in Panama City, Panama. Psychopharmacology Bulletin 12: 41–42 (1976). Vinar, O.; Topiar, A. and Muronova, J.: Trazodone in depressions. Activitas Nerovosa Superior 21: 148–150 (1979). Vinci, M.: Clinical report on the use of trazodone, AF-1161, in endogenous depression. Ospedale psichiatrico 39: 416–433 (1971). Wheatley, D.. Evaluation of trazodone in the treatment of anxiety. Current Therapeutic Research 20(1): 74–83 (1976). Wheatley, D.: Trazodone in mixed neuroses, in Morozov, Saarma and Silvestrini (Eds) Depression and the Role of Trazodone in Antidepressant Therapy. Proceedings of the USSR; the Serbsky Central Research Institute of Forensic Psychiatry and the F. Angelini Research Institute, Rome, Italy, Moscow, June 28–30, 1977. pp.117–123 (Edizioni Luigi Pozzi S.p.A. — Rome 1978). Wheatley, D.: Trazodone in depression. International Pharmacopsychiatry. In press (1981a). Wheatley, D.: The side effects profile of the new antidepressants. Journal of the Royal Society of Medicine. Special issue, in press (1981b). Yamato, C; Takahashi, T. and Fujita, T.: Studies on metabolism of trazodone. I. Metabolic fate of (14C) trazodone hydrochloride in rats. Xenobiotica 4(5): 313–326 (1974). Yamato, C.; Takahashi, T. and Fujita, T.: Studies on metabolism of trazodone. III. Species differences. Xenobiotica 6(5): 295–306 (1976a). Yamato, C.; Takahashi, T. and Fujita, T.: Studies on metabolism of trazodone. IV. Intestinal absorption in rats and rabbits. Xenobiotica 6(9): 521–529 (1976b). Yamatsu, K.; Kaneko, T.; Yamanishi, Y.; Kitahara, A. and Ohitake, S.: A possible mechanism of central action of trazodone in rats; in Ban and Silvestrini (Eds) Trazodone. Proceedings of the First International Symposium, Montreal, Quebec, October 1973. Vol. 9. Modern Problems of Pharmacopsychiatry, pp. 11–17 (Karger, Basel 1974).